Terms: = Colorectal cancer AND ERBB2, c-erb B2, 2064, P04626, ENSG00000141736, c-erbB2, HER-2/neu, HER2, TKR1, NEU, NGL, HER-2 AND Treatment
595 results:
1. Genomic Alterations and Clinical Characterization in Chinese Patients with Metastatic colorectal cancer.
Zhang XH; Zhou JQ; Wei Q; Li J; Xu T; Bai CM; Zhou JF; Wang XC
Discov Med; 2024 Jul; 36(186):1477-1485. PubMed ID: 39054718
[TBL] [Abstract] [Full Text] [Related]
2. Current and Emerging treatment Paradigms in colorectal cancer: Integrating Hallmarks of cancer.
Salva de Torres C; Baraibar I; Saoudi González N; Ros J; Salva F; Rodríguez-Castells M; Alcaraz A; García A; Tabernero J; Élez E
Int J Mol Sci; 2024 Jun; 25(13):. PubMed ID: 39000083
[TBL] [Abstract] [Full Text] [Related]
3. Progress in clinical diagnosis and treatment of colorectal cancer with rare genetic variants.
Chen S; Gu J; Wu K; Zhao X; Lu Y
Cancer Biol Med; 2024 Jun; 21(6):473-83. PubMed ID: 38940668
[TBL] [Abstract] [Full Text] [Related]
4. Immunohistochemical Expression of Human Epidermal Growth Factor Receptor 2 and Ki67 in Apocrine Gland Anal Sac Adenocarcinoma.
Paiva F; Santos J; Carra G; Sueiro F; Jark P; Nardi A
Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928157
[TBL] [Abstract] [Full Text] [Related]
5. Temporal and spatial heterogeneity of her2 status in metastatic colorectal cancer.
D'Angelo F; Monnien F; Overs A; Pem I; Dor F; Abad M; Felix S; Selmani Z; Lakkis Z; Borg C; Doussot A; Bibeau F; Molimard C
Diagn Pathol; 2024 Jun; 19(1):88. PubMed ID: 38909265
[TBL] [Abstract] [Full Text] [Related]
6. Comprehensive genomic profiling and therapeutic implications for Taiwanese patients with treatment-naïve breast cancer.
Chen SH; Tse KP; Lu YJ; Chen SJ; Tian YF; Tan KT; Li CF
Cancer Med; 2024 Jun; 13(12):e7384. PubMed ID: 38895905
[TBL] [Abstract] [Full Text] [Related]
7. treatment of patients with carcinomas in advanced stages with 5-fluorouracil, folinic acid and pyridoxine in tandem.
Machover D; Almohamad W; Castagné V; Desterke C; Gomez L; Goldschmidt E
Sci Rep; 2024 May; 14(1):12054. PubMed ID: 38802419
[TBL] [Abstract] [Full Text] [Related]
8. Plasma ctDNA enhances the tissue-based detection of oncodriver mutations in colorectal cancer.
Wang W; Huang Y; Kong J; Lu L; Liao Q; Zhu J; Wang T; Yan L; Dai M; Chen Z; You J
Clin Transl Oncol; 2024 Aug; 26(8):1976-1987. PubMed ID: 38777950
[TBL] [Abstract] [Full Text] [Related]
9. Epidermal growth factor receptor antagonists in colorectal cancer: emerging strategies for precision therapy.
González NS; Marchese PV; Baraibar I; Ros J; Salvà F; Rodríguez M; Salvà C; Vaghi C; Alcaraz A; García A; Tabernero J; Élez E
Expert Opin Investig Drugs; 2024 Jun; 33(6):613-625. PubMed ID: 38775361
[TBL] [Abstract] [Full Text] [Related]
10. Pembrolizumab Plus mFOLFOX7 or FOLFIRI for Microsatellite Stable/Mismatch Repair-Proficient Metastatic colorectal cancer: KEYNOTE-651 Cohorts B and D.
Kim R; Tehfe M; Kavan P; Chaves J; Kortmansky JS; Chen EX; Lieu CH; Wong L; Fakih M; Spencer K; Zhao Q; Predoiu R; Li C; Leconte P; Adelberg D; Chiorean EG
Clin Colorectal Cancer; 2024 Jun; 23(2):118-127.e6. PubMed ID: 38762348
[TBL] [Abstract] [Full Text] [Related]
11. Biomarker-oriented chemo-immunotherapy for advanced gastric cancer.
Kono K; Nakajima S; Mimura K
Int J Clin Oncol; 2024 Jul; 29(7):865-872. PubMed ID: 38647874
[TBL] [Abstract] [Full Text] [Related]
12. Telangiectasias induced by combination tucatinib and ado-trastuzumab emtansine in a patient with metastatic breast cancer.
Rodriguez GF; Shah A; Maderal AD
Breast Dis; 2024; 43(1):61-64. PubMed ID: 38578876
[TBL] [Abstract] [Full Text] [Related]
13. Fruquintinib as new treatment option in metastatic colorectal cancer patients: is there an optimal sequence?
Stucchi E; Bartolini M; Airoldi M; Fazio R; Daprà V; Mondello G; Prete MG; Puccini A; Santoro A
Expert Opin Pharmacother; 2024 Mar; 25(4):371-382. PubMed ID: 38568032
[TBL] [Abstract] [Full Text] [Related]
14. her2-Positive Metastatic colorectal cancer.
Robinson HR; Messersmith WA; Lentz RW
Curr Treat Options Oncol; 2024 May; 25(5):585-604. PubMed ID: 38539034
[TBL] [Abstract] [Full Text] [Related]
15. Gastroesophageal Adenocarcinomas With Defective Mismatch Repair: Current Knowledge and Clinical Management.
Strickland MR; Lander EM; Gibson MK; Ilson DH; Ajani JA; Klempner SJ
J Natl Compr Canc Netw; 2024 Mar; 22(3):. PubMed ID: 38503041
[TBL] [Abstract] [Full Text] [Related]
16. Molecular and Clinical Determinants of Acquired Resistance and treatment Duration for Targeted Therapies in colorectal cancer.
Harrold E; Keane F; Walch H; Chou JF; Sinopoli J; Palladino S; Al-Rawi DH; Chadalavada K; Manca P; Chalasani S; Yang J; Cercek A; Shia J; Capanu M; Bakhoum SF; Schultz N; Chatila WK; Yaeger R
Clin Cancer Res; 2024 Jun; 30(12):2672-2683. PubMed ID: 38502113
[TBL] [Abstract] [Full Text] [Related]
17. Trastuzumab plus pertuzumab for her2-amplified advanced colorectal cancer: Results from the drug rediscovery protocol (DRUP).
Spiekman IAC; Zeverijn LJ; Geurts BS; Verkerk K; Haj Mohammad SF; van der Noort V; Roepman P; de Leng WWJ; Jansen AML; Gootjes EC; de Groot DA; Kerver ED; van Voorthuizen T; Roodhart JML; Valkenburg-van Iersel LBJ; Gelderblom H; Voest EE; Verheul HMW
Eur J Cancer; 2024 May; 202():113988. PubMed ID: 38471288
[TBL] [Abstract] [Full Text] [Related]
18.
Battaglin F; Ou FS; Qu X; Hochster HS; Niedzwiecki D; Goldberg RM; Mayer RJ; Ashouri K; Zemla TJ; Blanke CD; Venook AP; Kabbarah O; Lenz HJ; Innocenti F
J Clin Oncol; 2024 Jun; 42(16):1890-1902. PubMed ID: 38457761
[TBL] [Abstract] [Full Text] [Related]
19. Synergistic antitumor activity between her2 antibody-drug conjugate and chemotherapy for treating advanced colorectal cancer.
Liu H; Zhou D; Liu D; Xu X; Zhang K; Hu R; Xiong P; Wang C; Zeng X; Wang L; Zhang S
Cell Death Dis; 2024 Mar; 15(3):187. PubMed ID: 38443386
[TBL] [Abstract] [Full Text] [Related]
20. her2 evaluation for clinical decision making in human solid tumours: pearls and pitfalls.
Zhang H; Finkelman BS; Ettel MG; Velez MJ; Turner BM; Hicks DG
Histopathology; 2024 Jul; 85(1):3-19. PubMed ID: 38443321
[TBL] [Abstract] [Full Text] [Related]
[Next]
